Document is current
Any future updates will be listed below
-
Authors
Rämet, Mika
Simon, Mike
-
Funding
Funding for this research was provided by:
Sanofi Pasteur
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 13 May 2026
First Online: 8 June 2026
Declarations
:
: Mika Rämet declares that his institution was sponsored by Sanofi to perform the MEQ73 study. Finnish Vaccine Research Ltd. (formerly Tampere University Vaccine Research Center) carries out clinical vaccine trials sponsored by all major vaccine manufacturers including Sanofi. Mike Simon declares that he is a clinical investigator for Sanofi, GlaxoSmithKline, Moderna, AbbVie and Novan.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
